GemPharmatech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	793.25	686.28	621.73	515.67	392.44
Other Revenue	-	0.56	0.45	0.87	1.34
Revenue	793.25	686.84	622.19	516.55	393.79
Revenue Growth (YoY)	15.49%	10.39%	20.45%	31.17%	50.35%
Cost of Revenue	-	261.33	202.86	150.22	101.27
Gross Profit	793.25	425.51	419.33	366.33	292.51
Selling, General & Admin	-	239.68	199.61	174.76	134.42
Research & Development	-	87.13	96.6	82.93	55.2
Other Operating Expenses	628.7	3.57	2.61	1.72	1.59
Operating Expenses	628.7	333.68	307.91	267.94	196.11
Operating Income	164.55	91.83	111.42	98.39	96.4
Interest Expense	-	-4.3	-2.76	-0.5	-0.74
Interest & Investment Income	-	22.39	28.65	23.73	14.43
Currency Exchange Gain (Loss)	-	1.69	0.08	1.49	-0.19
Other Non Operating Income (Expenses)	-0.2	-21.56	-20.92	-11.32	-16.05
EBT Excluding Unusual Items	164.36	90.06	116.48	111.8	93.84
Gain (Loss) on Sale of Investments	-	2.34	2.73	-0.05	0.32
Gain (Loss) on Sale of Assets	-	0.01	-0.02	-0.1	0.05
Other Unusual Items	-	26.8	42.1	62.03	49.1
Pretax Income	164.36	119.22	161.29	173.68	143.31
Income Tax Expense	19.96	9.4	2.37	9.02	18.39
Earnings From Continuing Operations	144.4	109.82	158.91	164.67	124.93
Net Income	144.4	109.82	158.91	164.67	124.93
Net Income to Common	144.4	109.82	158.91	164.67	124.93
Net Income Growth	31.49%	-30.89%	-3.49%	31.81%	63.45%
Shares Outstanding (Basic)	413	407	407	392	357
Shares Outstanding (Diluted)	413	407	407	392	357
Shares Change (YoY)	1.43%	-0.18%	3.93%	9.84%	-1.93%
EPS (Basic)	0.35	0.27	0.39	0.42	0.35
EPS (Diluted)	0.35	0.27	0.39	0.42	0.35
EPS Growth	29.63%	-30.77%	-7.14%	20.00%	66.67%
Free Cash Flow	-	-23.36	-89.33	-84.33	24.24
Free Cash Flow Per Share	-	-0.06	-0.22	-0.21	0.07
Dividend Per Share	-	0.140	0.160	0.041	-
Dividend Growth	-	-12.50%	290.24%	-	-
Gross Margin	100.00%	61.95%	67.40%	70.92%	74.28%
Operating Margin	20.74%	13.37%	17.91%	19.05%	24.48%
Profit Margin	18.20%	15.99%	25.54%	31.88%	31.72%
Free Cash Flow Margin	-	-3.40%	-14.36%	-16.33%	6.16%
EBITDA	237.34	164.62	157.42	135.68	125.2
EBITDA Margin	29.92%	23.97%	25.30%	26.27%	31.80%
D&A For EBITDA	72.79	72.79	46	37.29	28.81
EBIT	164.55	91.83	111.42	98.39	96.4
EBIT Margin	20.74%	13.37%	17.91%	19.05%	24.48%
Effective Tax Rate	12.14%	7.88%	1.47%	5.19%	12.83%
Revenue as Reported	-	686.84	622.19	516.55	393.79
Advertising Expenses	-	2.93	4.69	8.94	2.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.